Neumora Therapeutics
NMRA
NMRA
115 hedge funds and large institutions have $65.2M invested in Neumora Therapeutics in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
34% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 50
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
92% less capital invested
Capital invested by funds: $852M → $65.2M (-$786M)
Holders
115
Holding in Top 10
1
Calls
$282K
Puts
$130K
Top Buyers
| 1 | +$1.86M | |
| 2 | +$1.4M | |
| 3 | +$1.26M | |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$1.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$774K |
Top Sellers
| 1 | -$42.4M | |
| 2 | -$39.2M | |
| 3 | -$22M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$10.1M |
| 5 |
O
OrbiMed
New York
|
-$8.53M |
